In contrast to FSHD2 individuals, BAMS patients show no signs of muscular dystrophy while SMCHD1 mutations in FSHD2 are not associated with craniofacial defects, which are characteristic for BAMS. The gene discussed is SMCHD1; the disease is arhinia, choanal atresia, and microphthalmia.